Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Oxidative Medicine and Cellular Longevity|July 9, 2019
High Levels of <i>β</i>-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated MouseRebecca Piccarducci, Deborah Pietrobono, Carolina Pellegrini, et al.
Restorative Dentistry & Endodontics|September 9, 2024
A 48-month clinical performance of hybrid ceramic fragment restorations manufactured in CAD/CAM in non-carious cervical lesions: case reportMichael Willian Favoreto, Gabriel David Cochinski, Eveline Claudia Martini, et al.
Psychopharmacology|April 15, 2005
Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptomsStefano Pini, Claudia Martini, Marianna Abelli, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 7, 2002
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligandsAntonio Di Stefano, Piera Sozio, Grazia Luisi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2015
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic studyGabriella Guerrini, Giovanna Ciciani, Samuele Ciattini, et al.
Bioorganic & Medicinal Chemistry|November 19, 2011
Development of ligands at γ-aminobutyrric acid type A (GABAA) receptor subtype as new agents for pain reliefGabriella Guerrini, Giovanna Ciciani, Fabrizio Bruni, et al.
Cellular Signalling|August 26, 2014
Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validationCristina Sensi, Simona Daniele, Chiara Parravicini, et al.
Biomedical Journal|April 7, 2024
Blood oxygenation state in COVID-19 patients: Unexplored role of 2,3-bisphosphoglycerateMaria Sofia Bertilacchi, Rebecca Piccarducci, Alessandro Celi, et al.
European Journal of Medicinal Chemistry|October 21, 2020
An update into the medicinal chemistry of translocator protein (TSPO) ligandsElisabetta Barresi, Marco Robello, Barbara Costa, et al.
ACS Chemical Neuroscience|August 4, 2012
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effectsAlessia Scatena, Francesco Fornai, Maria Letizia Trincavelli, et al.
Pageof 31